Why are inhaled steroids used to treat asthma and copd
Pro Research Analysisby 
Searched over 200M research papers
The Role of Inhaled Steroids in Treating Asthma and COPD
Introduction to Inhaled Steroids
Inhaled corticosteroids (ICS) are a cornerstone in the management of asthma and chronic obstructive pulmonary disease (COPD). These medications are primarily used to reduce inflammation in the airways, which is a common underlying factor in both conditions. The effectiveness and application of ICS, however, vary between asthma and COPD due to differences in the pathophysiology of these diseases.
Mechanism of Action: Reducing Airway Inflammation
Asthma
In asthma, inflammation of the airway wall is a major pathophysiological mechanism. ICS work by switching off multiple activated inflammatory genes through reversing histone acetylation via the recruitment of histone deacetylase 2 (HDAC2). This suppression of airway inflammation reduces airway hyperresponsiveness and controls asthma symptoms . ICS are the first-line therapy for all patients with persistent asthma, effectively controlling symptoms and preventing exacerbations Barnes2010Raissy2013.
COPD
In COPD, the inflammation is more resistant to the action of corticosteroids due to a reduction in HDAC2 activity and expression as a result of oxidative stress . Despite this, ICS are still used in COPD, particularly in combination with bronchodilators, to reduce exacerbations in patients with severe disease Barnes2010Raissy2013. However, the overall clinical benefit in COPD is less pronounced compared to asthma.
Clinical Benefits and Efficacy
Asthma
ICS have been convincingly shown to be effective in both acute exacerbations and chronic management of asthma. They improve lung function, alleviate symptoms of airway obstruction, and decrease bronchial hyperreactivity . Long-term studies have demonstrated that maintenance treatment with ICS is beneficial, leading to better control of asthma and a reduction in severe exacerbations Schayck1996Miller‐Larsson2006.
COPD
The efficacy of ICS in COPD is less clear. While they are commonly prescribed to treat exacerbations, their long-term benefit is not as well established. Some patients with COPD may respond to ICS after prolonged therapy, but this response is not universal . Therapeutic trials are recommended to identify patients who may benefit from long-term ICS treatment Zainudin1997Schayck1996.
Safety Profile and Side Effects
Asthma
The inhaled route of administration maximizes delivery to the airways and minimizes systemic exposure, thereby increasing the therapeutic ratio. Most side effects are localized to the oropharynx, such as irritation, candidiasis, and dysphonia, which can be managed easily . Systemic side effects, such as osteoporosis and adrenal insufficiency, are more concerning with high doses but are generally rare at the doses used for asthma .
COPD
In COPD, the use of high-dose ICS can lead to systemic side effects, including an increased risk of pneumonia Barnes2010Itoh2016. Therefore, the benefits of ICS must be weighed against the potential risks, especially in long-term use.
Combination Therapy: ICS and Long-Acting Beta-Agonists (LABA)
Combining ICS with long-acting beta-agonists (LABA) has shown superior control of both asthma and COPD. This combination addresses both bronchoconstriction and inflammation, leading to improved lung function and reduced exacerbations . The combination therapy is particularly effective in asthma, where it enhances the efficacy of ICS and improves patient compliance .
Conclusion
Inhaled corticosteroids play a crucial role in the management of asthma and COPD by reducing airway inflammation and improving lung function. While their efficacy is well-established in asthma, their benefit in COPD is more variable and requires careful patient selection. The combination of ICS with LABA offers enhanced control of symptoms and is a common therapeutic strategy in both conditions. Despite the potential for side effects, the benefits of ICS, particularly in asthma, make them indispensable in the treatment of obstructive airway diseases.
Sources and full results
Most relevant research papers on this topic